Bjorn Kluwe1, Robin Ortiz2, James B Odei3, Songzhu Zhao1, David Kline1, Guy Brock1, Justin B Echouffo-Tcheugui4, Ju-Mi Lee5, Sophie Lazarus6, Teresa Seeman7, Philip Greenland8, Belinda Needham9, Mercedes R Carnethon8, Sherita H Golden4, Joshua J Joseph10. 1. The Ohio State University College of Medicine, Columbus, OH, United States. 2. Department of Internal Medicine and Pediatrics, University of Pennsylvania, Philadelphia, PA, United States. 3. Division of Biostatistics, The Ohio State University College of Public Health, Columbus, OH, United States. 4. Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, United States. 5. Department of Preventative Medicine, Eulji University College of Medicine, Daejeon, South Korea. 6. Department of Psychiatry and Behavioral Health, The Ohio State University College of Medicine, Columbus, OH, United States. 7. Division of Geriatrics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States. 8. Department of Preventive Medicine, Northwestern University, Chicago, IL, United States. 9. Department of Epidemiology, University of Michigan, Ann Arbor, MI, United States. 10. The Ohio State University College of Medicine, Columbus, OH, United States. Electronic address: joseph.117@osu.edu.
Abstract
INTRODUCTION: A flatter diurnal cortisol curve has been associated with incident diabetes among older white adults. However, this relationship has not been examined among middle-aged individuals or African Americans [AA]. We analyzed the longitudinal association of baseline diurnal cortisol curve features with incident diabetes over a 10 year period in a cohort of AA and white participants who were, on average, 40 years old. METHODS: Salivary cortisol was collected immediately post-awakening, then subsequently 45 min, 2.5 h, 8 h, and 12 h later, as well as at bedtime. Cortisol curve features included wake-up cortisol; cortisol awakening response (CAR); early, late, and overall decline slopes; bedtime cortisol; and 16 -h area under the curve (AUC). Salivary cortisol (nmol/L) was log-transformed due to positively skewed distributions. Diabetes was defined as fasting plasma glucose ≥ 126 mg/dL or taking diabetes medication. Logistic regression models were used to investigate the association of log-transformed cortisol curve features with incident diabetes. The analysis was stratified by race and adjusted for age, sex, education, depressive symptoms, smoking status, beta-blocker and steroid medication use and BMI. RESULTS: Among 376 AA and 333 white participants (mean age 40 years), 67 incident diabetes cases occurred over 10 years. After full adjustment for additional covariates, a 1-unit log increase in CAR was associated with a 53 % lower odds of incident diabetes among whites (Odds Ratio [OR] 0.47, 95 % CI: 0.24, 0.90). A 1-SD increase in late decline slope was associated with a 416 % higher odds of incident diabetes among whites (OR 5.16, 95 % CI: 1.32, 20.20). There were no significant associations in AAs. CONCLUSION: A robust CAR and flatter late decline slope are associated with lower and higher odds of incident diabetes, respectively, among younger to middle-aged whites and may provide a future target for diabetes prevention in this population.
INTRODUCTION: A flatter diurnal cortisol curve has been associated with incident diabetes among older white adults. However, this relationship has not been examined among middle-aged individuals or African Americans [AA]. We analyzed the longitudinal association of baseline diurnal cortisol curve features with incident diabetes over a 10 year period in a cohort of AA and white participants who were, on average, 40 years old. METHODS: Salivary cortisol was collected immediately post-awakening, then subsequently 45 min, 2.5 h, 8 h, and 12 h later, as well as at bedtime. Cortisol curve features included wake-up cortisol; cortisol awakening response (CAR); early, late, and overall decline slopes; bedtime cortisol; and 16 -h area under the curve (AUC). Salivary cortisol (nmol/L) was log-transformed due to positively skewed distributions. Diabetes was defined as fasting plasma glucose ≥ 126 mg/dL or taking diabetes medication. Logistic regression models were used to investigate the association of log-transformed cortisol curve features with incident diabetes. The analysis was stratified by race and adjusted for age, sex, education, depressive symptoms, smoking status, beta-blocker and steroid medication use and BMI. RESULTS: Among 376 AA and 333 white participants (mean age 40 years), 67 incident diabetes cases occurred over 10 years. After full adjustment for additional covariates, a 1-unit log increase in CAR was associated with a 53 % lower odds of incident diabetes among whites (Odds Ratio [OR] 0.47, 95 % CI: 0.24, 0.90). A 1-SD increase in late decline slope was associated with a 416 % higher odds of incident diabetes among whites (OR 5.16, 95 % CI: 1.32, 20.20). There were no significant associations in AAs. CONCLUSION: A robust CAR and flatter late decline slope are associated with lower and higher odds of incident diabetes, respectively, among younger to middle-aged whites and may provide a future target for diabetes prevention in this population.
Authors: A Schmidt-Reinwald; J C Pruessner; D H Hellhammer; I Federenko; N Rohleder; T H Schürmeyer; C Kirschbaum Journal: Life Sci Date: 1999 Impact factor: 5.037
Authors: Arun S Karlamangla; Esther M Friedman; Teresa E Seeman; Robert S Stawksi; David M Almeida Journal: Psychoneuroendocrinology Date: 2013-07-04 Impact factor: 4.905
Authors: Emma K Adam; Jennifer A Heissel; Katharine H Zeiders; Jennifer A Richeson; Emily C Ross; Katherine B Ehrlich; Dorainne J Levy; Margaret Kemeny; Amanda B Brodish; Oksana Malanchuk; Stephen C Peck; Thomas E Fuller-Rowell; Jacquelynne S Eccles Journal: Psychoneuroendocrinology Date: 2015-08-28 Impact factor: 4.905
Authors: Esther Donga; Marieke van Dijk; J Gert van Dijk; Nienke R Biermasz; Gert-Jan Lammers; Klaas W van Kralingen; Eleonara P M Corssmit; Johannes A Romijn Journal: J Clin Endocrinol Metab Date: 2010-04-06 Impact factor: 5.958
Authors: A S DeSantis; A V DiezRoux; A Hajat; A E Aiello; S H Golden; N S Jenny; T E Seeman; S Shea Journal: Psychoneuroendocrinology Date: 2011-12-16 Impact factor: 4.905
Authors: Robin Ortiz; Joshua J Joseph; Charlie C Branas; John M MacDonald; Max Jordan Nguemeni Tiako; Kehinde Oyekanmi; Eugenia C South Journal: Compr Psychoneuroendocrinol Date: 2022-05-28